We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

64 hedge funds and large institutions have $595M invested in IVERIC bio, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,852% more call options, than puts

Call options by funds: $4.03M | Put options by funds: $58K

1,727% more capital invested

Capital invested by funds: $32.6M → $595M (+$562M)

917% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 6

611% more funds holding

Funds holding: 9 → 64 (+55)

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
64
Holders Change
+55
Holders Change %
+611.11%
% of All Funds
1.86%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.09%
New
61
Increased
1
Reduced
2
Closed
6
Calls
$4.03M
Puts
$58K
Net Calls
+$3.97M
Net Calls Change
+$3.97M

Top Buyers

1
NHAS
Novo Holdings A/S
Denmark
+$205M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$55.7M
3
RCM
RA Capital Management
Massachusetts
+$47.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$24.6M
5
EAM
Eagle Asset Management
Florida
+$19.1M

Top Sellers

1
CWAM
Columbia Wanger Asset Management
Illinois
-$7.84M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.78M
3
VM
VHCP Management
New York
-$1.56M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.16M
5
ICAP
Independence Capital Asset Partners
Colorado
-$1.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$223M +$205M +6,896,819 New
CV
2
Clarus Ventures
Massachusetts
$98.8M +$90.6M +3,054,744 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$60.8M +$55.7M +1,878,763 New
RCM
4
RA Capital Management
Massachusetts
$51.8M +$47.5M +1,600,455 New
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$26.8M +$24.6M +829,123 New
EAM
6
Eagle Asset Management
Florida
$20.8M +$19.1M +642,693 New
ICAP
7
Independence Capital Asset Partners
Colorado
$11.9M -$1.13M -38,165 -9%
RG
8
Redmile Group
California
$10.2M +$9.39M +316,521 New
BA
9
BlackRock Advisors
Delaware
$8.55M +$7.84M +264,244 New
JCG
10
JHL Capital Group
Illinois
$7.93M +$1.63M +55,000 +29%
BFA
11
BlackRock Fund Advisors
California
$7.09M +$6.5M +219,040 New
Morgan Stanley
12
Morgan Stanley
New York
$6.83M +$6.26M +211,034 New
Vanguard Group
13
Vanguard Group
Pennsylvania
$5.9M +$5.41M +182,299 New
BC
14
Broadfin Capital
New York
$4.85M +$4.45M +150,000 New
BIT
15
BlackRock Institutional Trust
California
$4.67M +$4.29M +144,458 New
State Street
16
State Street
Massachusetts
$4.21M +$3.86M +130,259 New
Northern Trust
17
Northern Trust
Illinois
$3.86M +$3.54M +119,320 New
PC
18
Pier Capital
Connecticut
$3.47M +$3.19M +107,355 New
BBA
19
Baker Bros. Advisors
New York
$3.33M +$3.06M +103,040 New
JP Morgan Chase
20
JP Morgan Chase
New York
$2.69M +$2.47M +83,296 New
Millennium Management
21
Millennium Management
New York
$2.43M +$2.23M +75,000 New
PA
22
Perceptive Advisors
New York
$2.43M +$2.23M +75,000 New
Barclays
23
Barclays
United Kingdom
$2.12M +$1.96M +66,231 New
BG
24
BlackRock Group
United Kingdom
$1.93M +$1.77M +59,694 New
Geode Capital Management
25
Geode Capital Management
Massachusetts
$1.78M +$1.63M +54,962 New
1
2 3

ISEE Hedge Fund Activity: Q4 2013 in Review

64 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2013, worth a combined $595M — up 1,727% from $32.6M a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new ISEE positions and 6 closed out — a net gain of 55 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $205M. The largest seller was Columbia Wanger Asset Management, exiting entirely with an estimated $7.84M sold.

  • 64 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2013, up from 9 in Q3 2013.
  • Funds reported $595M of IVERIC bio, Inc. Common Stock stock for Q4 2013, up 1,727% quarter-over-quarter.
  • 61 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2013 and 6 closed out, a net change of +55 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q4 2013 was Novo Holdings A/S, an estimated $205M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q4 2013 was Columbia Wanger Asset Management, an estimated $7.84M sold.

Based on aggregated 13F filings for Q4 2013.